The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

Chowdhury, Rasheduzzaman, Yeoh, Kar Kheng, Tian, Ya‐Min, Hillringhaus, Lars, Bagg, Eleanor A, Rose, Nathan R, Leung, Ivanhoe K H, Li, Xuan S, Woon, Esther C Y, Yang, Ming, McDonough, Michael A, King, Oliver N, Clifton, Ian J, Klose, Robert J, Claridge, Timothy D W, Ratcliffe, Peter J, Schofield, Christopher J, Kawamura, Akane·2011·The EMBO Reports

DOI 10.1038/embor.2011.43

Cited by (1,000)

Items 101–200 of 1,000

The crucial role of multiomic approach in cancer research and clinically relevant outcomes
Miaolong Lu, Xianquan Zhan · 2018 · The EPMA Journal
IDH Mutation in Glioma
Zorbey T. Turkalp, Jason Karamchandani, Sunit Das · 2014 · JAMA Neurology
Cancer Cell Metabolism
Rob A. Cairns, Isaac S. Harris, Susan A. McCracken, Tak W. Mak · 2011 · Cold Spring Harbor Symposia on Quantitative Biology
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
de Botton, Stephane, Mondesir, Johanna, Willekens, Christophe, Touat, Mehdi · 2016 · Journal of Blood Medicine
Oncometabolites in renal cancer
Cissy Yong, Grant Duncan Stewart, Christian Frezza · 2019 · Nature Reviews Nephrology
Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use
Zdzisińska, Barbara, Żurek, Aleksandra, Kandefer-Szerszeń, Martyna · 2017 · Archivum Immunologiae et Therapiae Experimentalis
Chromatin signatures of cancer
Marc A. Morgan, Ali Shilatifard · 2015 · Genes & Development
Cancer metabolism in space and time: Beyond the Warburg effect
Pierre Danhier, Piotr Bański, Valéry L. Payen, Debora Grasso, Luigi Ippolito, Pierre Sonveaux, Paolo Ettore Porporato · 2017 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
Undercover: gene control by metabolites and metabolic enzymes
Jan A. van der Knaap, C. Peter Verrijzer · 2016 · Genes & Development
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML
Chaturvedi, Anuhar, Araujo Cruz, Michelle Maria, Jyotsana, Nidhi, Sharma, Amit, Yun, Haiyang, Görlich, Kerstin, Wichmann, Martin, Schwarzer, Adrian, Preller, Matthias, Thol, Felicitas et al. · 2013 · Blood
Lactate dehydrogenase A silencing in IDH mutant gliomas
Chesnelong, Charles, Chaumeil, Myriam M., Blough, Michael D., Al-Najjar, Mohammad, Stechishin, Owen D., Chan, Jennifer A., Pieper, Russell O., Ronen, Sabrina M., Weiss, Samuel, Luchman, H. Artee et al. · 2014 · Neuro-Oncology
Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer
Owen Clark, Katharine E. Yen, Ingo K. Mellinghoff · 2016 · Clinical Cancer Research
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo
Janeta V. Popovici-Müller, Jeffrey O. Saunders, Francesco G. Salituro, Jeremy M. Travins, Shunqi Yan, Fang Zhao, Stefan Größ, Lenny Dang, Katharine E. Yen, Hua Yang et al. · 2012 · ACS Medicinal Chemistry Letters
Isocitrate Dehydrogenase Mutation and ( <i>R</i> )-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development
Dang, Lenny, Su, Shin-San Michael · 2017 · Annual Review of Biochemistry
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, Shengfang Ge, Peiwei Chai, Ai Zhuang, Xianqun Fan · 2022 · 癌症：英文版
TET proteins and 5‐methylcytosine oxidation in hematological cancers
Myunggon Ko, Jungeun An, William A. Pastor, Sergei B. Koralov, Klaus Rajewsky, Anjana Rao · 2014 · Immunological Reviews
Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d -2-Hydroxyglutarate
Jing Fan, Xin Teng, Ling Liu, Katherine R. Mattaini, Ryan Looper, Matthew G. Vander Heiden, Joshua D. Rabinowitz · 2014 · ACS Chemical Biology
Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents
Wang, Pu, Wu, Jing, Ma, Shenghong, Zhang, Lei, Yao, Jun, Hoadley, Katherine A., Wilkerson, Matthew D., Perou, Charles M., Guan, Kun-Liang, Ye, Dan et al. · 2015 · Cell Reports
Cancer as a Metabolic Disorder
Jones Gyamfi, Jinyoung Kim, Junjeong Choi · 2022 · International Journal of Molecular Sciences
Structures of Human ALKBH5 Demethylase Reveal a Unique Binding Mode for Specific Single-stranded N6-Methyladenosine RNA Demethylation
Chao Xu, Ke Liu, W. Tempel, Marina Demetriades, Wei Shen Aik, Christopher John Schofield, Jinrong Min · 2014 · Journal of Biological Chemistry
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2
Satoshi Inoue, Wanda Y. Li, Alan Tseng, Isabel Beerman, Andrew Elia, Sean C. Bendall, François Lemonnier, Ken J. Kron, David W. Cescon, Zhenyue Hao et al. · 2016 · Cancer Cell
Targeting histone lysine demethylases — Progress, challenges, and the future
Cyrille C. Thinnes, Katherine S. England, Akane Kawamura, Rasheduzzaman Chowdhury, Christopher John Schofield, Richard J. Hopkinson · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Molecular and cellular heterogeneity: the hallmark of glioblastoma
Diane J. Aum, David H. Kim, Thomas Beaumont, Eric C. Leuthardt, Gavin P. Dunn, Albert H. Kim · 2014 · Neurosurgical FOCUS
From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?
vel Szic, Katarzyna Szarc, Declerck, Ken, Vidaković, Melita, Vanden Berghe, Wim · 2015 · Clinical Epigenetics
Metabolism and Epigenetics
Ryan Janke, Anne E. Dodson, Jasper Rine · 2015 · Annual Review of Cell and Developmental Biology
DNA repair mechanisms and their clinical impact in glioblastoma
Hélène Erasimus, Matthieu Gobin, Simone P. Niclou, Eric Van Dyck · 2016 · Mutation Research/Reviews in Mutation Research
The emerging role of fumarate as an oncometabolite
Yang, Ming, Soga, Tomoyoshi, Pollard, Patrick J., Adam, Julie · 2012 · Frontiers in Oncology
Targeting histone lysine methylation in cancer
John P. McGrath, Patrick Trojer · 2015 · Pharmacology & Therapeutics
Applications of metabolomics to study cancer metabolism
Kaushik, Akash K., DeBerardinis, Ralph J. · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation
Remco Jurriaan Molenaar, Tomas Radivoyevitch, Jaroslaw Pawel Maciejewski, Cornelis J.F. Van Noorden, Fonnet E. Bleeker · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization
Patrick S. Ward, Chao Lü, Justin R. Cross, Omar Ibrahim Abdel-Wahab, Ross L. Levine, Gary K. Schwartz, Craig B. Thompson · 2012 · Journal of Biological Chemistry
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
Carbonneau, Mélissa, M. Gagné, Laurence, Lalonde, Marie-Eve, Germain, Marie-Anne, Motorina, Alena, Guiot, Marie-Christine, Secco, Blandine, Vincent, Emma E., Tumber, Anthony, Hulea, Laura et al. · 2016 · Nature Communications
Magnetic Resonance of 2-Hydroxyglutarate in IDH1 -Mutated Low-Grade Gliomas
Adam Elkhaled, Llewellyn E. Jalbert, Joanna J. Phillips, Hikari A. I. Yoshihara, Rupa Parvataneni, Radhika Srinivasan, G. Bourne, Mitchel Stuart Berger, Susan Marina Chang, Soonmee Cha et al. · 2012 · Science Translational Medicine
Oncometabolites: Unconventional triggers of oncogenic signalling cascades
Marco Sciacovelli, Christian Frezza · 2016 · Free Radical Biology and Medicine
Two-stage metabolic remodelling in macrophages in response to lipopolysaccharide and interferon-γ stimulation
Gretchen L. Seim, Emily C. Britt, Steven V John, Franklin J. Yeo, Aaron R. Johnson, Richard S. Eisenstein, David J. Pagliarini, Jing Fan · 2019 · Nature Metabolism
Metabolic symbiosis in cancer: Refocusing the Warburg lens
Erica C. Nakajima, Bennett Van Houten · 2012 · Molecular Carcinogenesis
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
Courtney Denton Dinardo, Anthony Selwyn Stein, Eytan M. Stein, Amir Tahmasb Fathi, Olga Frankfurt, Andre C. Schuh, Hartmut Döhner, Giovanni Martinelli, Prapti Arvind Patel, Emmanuel Raffoux et al. · 2020 · Journal of Clinical Oncology
A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation
Christopher G. Duncan, Benjamin G. Barwick, Genglin Jin, Carlo Rago, Priya Kapoor-Vazirani, Doris R. Powell, Jen‐Tsan Chi, Darell D. Bigner, Paula M. Vertino, Hai Yan · 2012 · Genome Research
Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate
Ovidiu C. Andronesi, Otto Rapalino, Elizabeth Robins Gerstner, Andrew S. Chi, Tracy T. Batchelor, Daniel P. Cahill, Alma Gregory Sorensen, Bruce Robert Rosen · 2013 · Journal of Clinical Investigation
IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition
Andrew M. Kernytsky, Fang Wang, Erica Hansen, Stefanie S. Schalm, Kimberly S. Straley, Camelia Gliser, Hua Qiang Yang, Jeremy M. Travins, Stuart Murray, Marion Dorsch et al. · 2014 · Blood
Mutant IDH1 and thrombosis in gliomas
Dusten J. Unruh, Steven R. Schwarze, Laith Khoury, Cheddhi Thomas, Meijing Wu, Li Chen, Rui Chen, Yinxing Liu, Margaret A. Schwartz, Christina Amidei et al. · 2016 · Acta Neuropathologica
Long-term reprogramming of the innate immune system
Jorge Domínguez‐Andrés, Mihai Gheorghe Netea · 2018 · Journal of Leukocyte Biology
Metabolic rewiring in melanoma
Boris I. Ratnikov, David A. Scott, Andrei L. Osterman, Jeffrey W. Smith, Ze’ev A. Ronai · 2016 · Oncogene
Sex Differences in Intestinal Carbohydrate Metabolism Promote Food Intake and Sperm Maturation
Bruno Hudry, Eva de Goeij, Alessandro Mineo, Pedro Gaspar, Dafni Hadjieconomou, Chris Studd, João Benhur Mokochinski, Holger Kramer, Pierre-Yves Plaçais, Thomas Préat et al. · 2019 · Cell
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Lee, Shen-Han, Golinska, Monika, Griffiths, John R. · 2021 · Cells
5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation
Richard J. Hopkinson, Anthony Tumber, Clarence Yapp, Rasheduzzaman Chowdhury, Wei Shen Aik, Ka Hing Che, Xuan Shirley Li, Jan B. L. Kristensen, Oliver N. F. King, Mun Chiang Chan et al. · 2013 · Chemical Science
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota, Matthew J Pun, Akash Deogharkar, Chan Chung, Rohinton S. Tarapore et al. · 2023 · Cancer Discovery
The Roles of Jumonji-Type Oxygenases in Human Disease
C. Johansson, Anthony Tumber, KaHing Che, Peter Cain, Radosław P. Nowak, C. Gileadi, Udo C. T. Oppermann · 2014 · Epigenomics
What do we know about IDH1/2 mutations so far, and how do we use it?
Craig Horbinski · 2013 · Acta Neuropathologica
Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions
Stephen P. Burr, Ana S.H. Costa, Guinevere L. Grice, Richard T. Timms, Ian T. Lobb, Peter Freisinger, Roger B. Dodd, Gordon Dougan, Paul J. Lehner, Christian Frezza et al. · 2016 · Cell Metabolism
Metabolic coordination of cell fate by α-ketoglutarate-dependent dioxygenases
Baksh, Sanjeethan C., Finley, Lydia W.S. · 2021 · Trends in Cell Biology
Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation
Roberta Leonardi, Chitra Subramanian, Suzanne Jackowski, Charles O. Rock · 2012 · Journal of Biological Chemistry
Structural Basis for Inhibition of the Fat Mass and Obesity Associated Protein (FTO)
Wei Shen Aik, Marina Demetriades, Muhammad K. K. Hamdan, Eleanor A. L. Bagg, Kar Kheng Yeoh, Clarisse Lejeune, Zhihong Zhang, M.A. McDonough, Christopher John Schofield · 2013 · Journal of Medicinal Chemistry
TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State
Simone Cardaci, Maria Rosa Ciriolo · 2012 · International Journal of Cell Biology
Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor
Justin A. Caravella, Jian Lin, R. Bruce Diebold, Ann-Marie Campbell, Anna M. Ericsson, Gary R. Gustafson, Zhongguo Wang, Jennifer Castro, Andrea Clarke, Deepali Gotur et al. · 2020 · Journal of Medicinal Chemistry
Cancer and Altered Metabolism: Potential Importance of Hypoxia-Inducible Factor and 2-Oxoglutarate-Dependent Dioxygenases
Kaelin, W. G. · 2011 · Cold Spring Harbor Symposia on Quantitative Biology
Plant Growth Regulator Daminozide Is a Selective Inhibitor of Human KDM2/7 Histone Demethylases
Nathan R. Rose, Esther C. Y. Woon, Anthony Tumber, Louise J. Walport, Rasheduzzaman Chowdhury, Xuan Shirley Li, Oliver N. F. King, Clarisse Lejeune, Stanley S. Ng, Tobias J. Krojer et al. · 2012 · Journal of Medicinal Chemistry
Metabolic consequences of oncogenic IDH mutations
Seth J. Parker, Christian M. Metallo · 2015 · Pharmacology & Therapeutics
Surgical resection of malignant gliomas—role in optimizing patient outcome
Ilker Yasin Eyüpoglu, Michael Buchfelder, Nicolai E. Savaskan · 2013 · Nature Reviews Neurology
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
Tap, William D., Villalobos, Victor M., Cote, Gregory M., Burris, Howard, Janku, Filip, Mir, Olivier, Beeram, Murali, Wagner, Andrew J., Jiang, Liewen, Wu, Bin et al. · 2020 · Journal of Clinical Oncology
Induction of sarcomas by mutant IDH2
Chao Lü, Sriram Venneti, Altuna Akalin, Fang Fang, Patrick S. Ward, Raymond G. Dematteo, Andrew M. Intlekofer, Chong Chen, Jiangbin Ye, Meera Hameed et al. · 2013 · Genes & Development
Hypothesis: Environmental regulation of 5-hydroxymethylcytosine by oxidative stress
Nancy Chia, Luan Wang, Xiangyi Lu, Marie‐Claude Senut, Carol A. Brenner, Douglas Mark Ruden · 2011 · Epigenetics
Mutant IDH Inhibits IFNγ–TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma
Meng‐Ju Wu, Lei Shi, Juan Dubrot, Joshua Merritt, Vindhya Vijay, Ting-Yu Wei, Emily Kessler, Kira E. Olander, Ramzi Adil, Amaya Pankaj et al. · 2021 · Cancer Discovery
Glutamate and α-ketoglutarate: key players in glioma metabolism
Andreas Maus, Godefridus J. Peters · 2016 · Amino Acids
The Roles of 2-Hydroxyglutarate
Xin Du, Hai Hu · 2021 · Frontiers in Cell and Developmental Biology
Oncometabolites‐driven tumorigenesis: From genetics to targeted therapy
Aurélie Morin, Éric Letouzé, Anne‐Paule Gimenez‐Roqueplo, Judith Favier · 2014 · International Journal of Cancer
Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis
Chiara Bardella, Osama Al‐Dalahmah, Daniel Krell, Pijus Brazauskas, Khalid Al‐Qahtani, Markéta Tomková, Julie Adam, Sébastien Serres, Helen E. Lockstone, Luke Freeman-Mills et al. · 2016 · Cancer Cell
Highly selective inhibition of histone demethylases by de novo macrocyclic peptides
Akane Kawamura, Martin Münzel, Tatsuya Kojima, Clarence Yapp, Bhaskar Bhushan, Yuki Goto, Anthony Tumber, Takayuki Katoh, Oliver N. F. King, Toby Passioura et al. · 2017 · Nature Communications
Radioprotection of <i>IDH1</i> -Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198
Molenaar, Remco J., Botman, Dennis, Smits, Myrthe A., Hira, Vashendriya V., van Lith, Sanne A., Stap, Jan, Henneman, Peter, Khurshed, Mohammed, Lenting, Krissie, Mul, Adri N. et al. · 2015 · Cancer Research
Lysine Demethylases Inhibitors
Takayoshi Suzuki, Naoki Miyata · 2011 · Journal of Medicinal Chemistry
Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China
Jiang-Han Wang, Wen‐Lian Chen, Junmin Li, Songfang Wu, Tianlu Chen, Yongmei Zhu, Weina Zhang, Yang Li, Yun-Ping Qiu, Ai-Hua Zhao et al. · 2013 · Proceedings of the National Academy of Sciences
Breathing-in epigenetic change with vitamin C
Monfort, Asun, Wutz, Anton · 2013 · The EMBO Reports
Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes
Brian W. Wong, Anna Kuchnio, Ulrike Brüning, Peter Carmeliet · 2012 · Trends in Biochemical Sciences
Oncometabolites: tailoring our genes
Stefan Nowicki, Eyal Gottlieb · 2015 · FEBS Journal
Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling
Laurence M. Gagné, Karine Boulay, Ivan Topisirović, Marc‐Étienne Huot, Frédérick A. Mallette · 2017 · Trends in Cell Biology
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate
Ovidiu C. Andronesi, Isabel Arrillaga‐Romany, Ina Ly, Wolfgang Bogner, Eva‐Maria Ratai, Kara Reitz, Anthony John Iafrate, Jörg Dietrich, Elizabeth Robins Gerstner, Andrew S. Chi et al. · 2018 · Nature Communications
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice
Padma Kadiyala, Stephen V. Carney, Jessica C. Gauss, María Belén Garcia-Fabiani, Santiago Haase, Mahmoud S. Alghamri, Felipe Javier Núñez, Yayuan Liu, Minzhi Yu, Ayman W. Taher et al. · 2020 · Journal of Clinical Investigation
Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models
Karuppagounder, Saravanan S., Alim, Ishraq, Khim, Soah J., Bourassa, Megan W., Sleiman, Sama F., John, Roseleen, Thinnes, Cyrille C., Yeh, Tzu-Lan, Demetriades, Marina, Neitemeier, Sandra et al. · 2016 · Science Translational Medicine
Selective Inhibition of Mutant Isocitrate Dehydrogenase 1 (IDH1) via Disruption of a Metal Binding Network by an Allosteric Small Molecule
Gejing Deng, Junqing Shen, Ming Yin, Jessica McManus, Magali Mathieu, Patricia Gee, Timothy He, Chaomei Shi, Olivier Bedel, Larry R. McLean et al. · 2014 · Journal of Biological Chemistry
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
Andrea Morandi, Maria Letizia Taddei, Paola Chiarugi, Elisa Giannoni · 2017 · Frontiers in Oncology
Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma
Borger, Darrell R., Goyal, Lipika, Yau, Thomas, Poon, Ronnie T., Ancukiewicz, Marek, Deshpande, Vikram, Christiani, David C., Liebman, Hannah M., Yang, Hua, Kim, Hyeryun et al. · 2014 · Clinical Cancer Research
Control of endothelial quiescence by FOXO-regulated metabolites
Jorge Andrade, Chenyue Shi, Ana S.H. Costa, Jeongwoon Choi, Jaeryung Kim, Anuradha Doddaballapur, Toshiya Sugino, Yu Ting Ong, Marco Castro, Barbara Zimmermann et al. · 2021 · Nature Cell Biology
Targeting mitochondria in cancer: current concepts and immunotherapy approaches
Sergei Pustylnikov, Francesca Costabile, Silvia Beghi, Andrea Facciabene · 2018 · Translational research
Cancer metabolism and tumor microenvironment: fostering each other?
Yiyuan Yuan, Huimin Li, Pu Wang, Leilei Chen, Dong Sheng Guo, Hongfei Jiang, Bo He, Siyuan Qin, Kui Wang, Na Li et al. · 2021 · Science China Life Sciences
mTORC2 in the center of cancer metabolic reprogramming
Kenta Masui, Webster K. Cavenee, Paul S. Mischel · 2014 · Trends in Endocrinology and Metabolism
Advances in histone demethylase KDM4 as cancer therapeutic targets
Dong Hoon Lee, Go Woon Kim, Yu Hyun Jeon, Jung Hoan Yoo, Sang Wu Lee, So Hee Kwon · 2020 · The FASEB Journal
2-Hydroxyglutarate in Cancer Cells
Ježek, Petr · 2020 · Antioxidants & Redox Signaling
Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia
Steven M. Chan, Ravindra Majeti · 2013 · International Journal of Hematology
IDH mutations in acute myeloid leukemia
Dinesh Rakheja, Sergej Naumovich Konoplev, Leonard Jeffrey Medeiros, Weina Chen · 2012 · Human Pathology
IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma
Chunzhi Zhang, Lynette M. Moore, Xia Li, W. K. Alfred Yung, Wei Zhang · 2013 · Neuro-Oncology
The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity
Renaud Vatrinet, Giulia Leone, Monica De Luise, Giulia Girolimetti, Michele Vidone, Giuseppe Gasparre, Anna Maria Porcelli · 2017 · Cancer & Metabolism
Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight
Hamoud Al‐Khallaf · 2017 · Cell & Bioscience
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia
Michael H. Kramer, Qiang Zhang, Robert W. Sprung, Ryan B. Day, Petra Erdmann-Gilmore, Yang Li, Ziheng Xu, Nichole Helton, Daniel R. George, Yiling Mi et al. · 2022 · Blood
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response
Amir T. Fathi, Hossein Sadrzadeh, Darrell R. Borger, Karen Kuhn Ballen, Philip C. Amrein, Eyal C. Attar, Julia Foster, Meghan E. Burke, Hector U. Lopez, Christina R. Matulis et al. · 2012 · Blood
Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
Vera Miranda‐Gonçalves, Ana Lameirinhas, Rui Henrique, Cármen Jerónimo · 2018 · Frontiers in Genetics
Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)
Alexandra R. Grassian, Fallon Lin, Rosemary Barrett, Yue Liu, Wei Jiang, Manav Korpal, Holly M. Astley, Daniel P. Gitterman, Thomas Henley, Rob Howes et al. · 2012 · Journal of Biological Chemistry
Alterations of metabolic genes and metabolites in cancer
Eric Karl Oermann, Jing Wu, Kun‐Liang Guan, Yue Xiong · 2012 · Seminars in Cell and Developmental Biology
Serum 2-Hydroxyglutarate Production in IDH1- and IDH2-Mutated De Novo Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
Maxime Janin, Elena Mylonas, Véronique Saada, Jean‐Baptiste Micol, Aline Renneville, Cyril Quivoron, Serge Koscielny, Laurianne Scourzic, Sébastien Forget, Cécile Pautas et al. · 2013 · Journal of Clinical Oncology
The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development
François Lemonnier, Rob A. Cairns, Satoshi Inoue, Wanda Y. Li, Aurélie Dupuy, Sophie Broutin, Nadine Martin, Virginie Fataccioli, Romain Pelletier, Andrew C. Wakeham et al. · 2016 · Proceedings of the National Academy of Sciences
Genetic alterations in Krebs cycle and its impact on cancer pathogenesis
Karishma Sajnani, Farhadul Islam, Robert Anthony Smith, Vinod Gopalan, Alfred King-yin Lam · 2017 · Biochimie